VWA7
von Willebrand factor A domain-containing protein 7
Also known as: C6orf27, G7c, NG37, VWA7_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y334
- Gene
- VWA7
- Ensembl
- ENSG00000204396
- Chromosome
- 6
- Canonical length
- 891 aa
- Protein class
- Predicted secreted proteins
- Subcellular location
- Plasma membrane,Cytosol
- Secretome location
- Secreted - unknown location
OverviewNCBI Gene
Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
891 residues, UniProt reviewed canonical sequence.
>Q9Y334|VWA7
1 MLPTEVPQSH PGPSALLLLQ LLLPPTSAFF PNIWSLLAAP GSITHQDLTE EAALNVTLQL
61 FLEQPPPGRP PLRLEDFLGR TLLADDLFAA YFGPGSSRRF RAALGEVSRA NAAQDFLPTS
121 RNDPDLHFDA ERLGQGRARL VGALRETVVA ARALDHTLAR QRLGAALHAL QDFYSHSNWV
181 ELGEQQPHPH LLWPRQELQN LAQVADPTCS DCEELSCPRN WLGFTLLTSG YFGTHPPKPP
241 GKCSHGGHFD RSSSQPPRGG INKDSTSPGF SPHHMLHLQA AKLALLASIQ AFSLLRSRLG
301 DRDFSRLLDI TPASSLSFVL DTTGSMGEEI NAAKIQARHL VEQRRGSPME PVHYVLVPFH
361 DPGFGPVFTT SDPDSFWQQL NEIHALGGGD EPEMCLSALQ LALLHTPPLS DIFVFTDASP
421 KDAFLTNQVE SLTQERRCRV TFLVTEDTSR VQGRARREIL SPLRFEPYKA VALASGGEVI
481 FTKDQHIRDV AAIVGESMAA LVTLPLDPPV VVPGQPLVFS VDGLLQKITV RIHGDISSFW
541 IKNPAGVSQG QEEGGGPLGH TRRFGQFWMV TMDDPPQTGT WEIQVTAEDT PGVRVQAQTS
601 LDFLFHFGIP MEDGPHPGLY PLTQPVAGLQ TQLLVEVTGL GSRANPGDPQ PHFSHVILRG
661 VPEGAELGQV PLEPVGPPER GLLAASLSPT LLSTPRPFSL ELIGQDAAGR RLHRAAPQPS
721 TVVPVLLELS GPSGFLAPGS KVPLSLRIAS FSGPQDLDLR TFVNPSFSLT SNLSRAHLEL
781 NESAWGRLWL EVPDSAAPDS VVMVTVTAGG REANPVPPTH AFLRLLVSAP APQDRHTTPT
841 GSSDPILTTA TPAFSPFTLV TQGRAGAGLA AGSPWWGTVG GVLLLLGLAS WLocalizationUniProt · AlphaFold · HPA
Whether an antibody against VWA7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 20 nTPM
- skeletal muscle: 6.2 nTPM
- cerebral cortex: 6 nTPM
- fallopian tube: 5.9 nTPM
- kidney: 5.4 nTPM
- endometrium: 5.3 nTPM
Single-cell type
- fallopian tube ciliated cells: 3.1 nCPM
- renal connecting tubule cells: 2.6 nCPM
- renal collecting duct principal cells: 2.4 nCPM
- podocytes: 2.3 nCPM
- proximal tubule cells: 2.2 nCPM
- loop of henle epithelial cells: 2.1 nCPM
Immune cell
- basophil: 0.5 nTPM
- T-reg: 0.2 nTPM
- gdT-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- hypothalamus: 26 nTPM
- pons: 22 nTPM
- medulla oblongata: 16 nTPM
- cerebral cortex: 15 nTPM
- midbrain: 11 nTPM
- white matter: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.87
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.01
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
- von Willebrand factor A-like domain superfamily
- Hemicentin/VWA7, galactose-binding domain-like
- Hemicentin-1-like, von Willebrand factor A domain
- Hemicentin galactose-binding domain-like
- von Willebrand factor A domain
- VWA7
- VWA7, N-terminal domain
- VWA7, beta-sandwich domain
- VWA7, Ig-like domain
- VWA7 beta-sandwich domain
- VWA7 Ig-like domain
- VWA7 N-terminal domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads VWA7 as an antibody target. Whether an autoantibody or antibody against VWA7 could matter depends on whether native VWA7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
VWA7 is annotated as secreted, so native VWA7 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label VWA7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...